Menu

2025年他泽司他正版的价格是多少?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Tazerestat is a targeted therapy for specific cancers, mainly used in the treatment of epithelioid sarcoma and follicular lymphoma. In 2025, its genuine price will vary depending on specifications and manufacturers, and patients need to choose the appropriate version according to their own needs. In addition, the usage of tazerestat and the medication for special groups must strictly follow the doctor's instructions.

What is the price of the genuine version of tazerestat in 2025?

As an important anti-cancer drug, its price varies depending on specifications and manufacturers. In 2025, there are mainly versions on the market such as Laos Lucius, Laos Big Bear, and original pharmaceutical versions exported to Hong Kong, with prices ranging from a few hundred dollars to several thousand dollars.

Laos Lucius version

The specification of Tazerestat produced by Laos Lucius is 200mg*56 tablets/box, with a reference price of approximately US$777. This version is suitable for patients with short-term treatment needs, and the price is relatively low, but attention should be paid to the authenticity and shelf life of the medicine.

Laos Big Bear Version

The specification of tazerestat provided by Laos Big Bear is 200mg*80 tablets/box, and the reference price is about US$1,480. Compared with the Lucius version, the Big Bear version has more tablets and is suitable for patients who require long-term treatment.

Export Hong Kong original pharmaceutical version

The specification of tazerestat exported to Hong Kong original pharmaceutical version is 200mg*240 tablets/box, and the reference price is about US$7,213. This version is suitable for patients with longer treatment cycles and is more expensive, but the quality of the drugs is more guaranteed.

When purchasing tazerestat, patients should obtain it through formal channels and carefully check the packaging and production date of the drug to avoid purchasing fake or inferior drugs.

Usage of tazerestat

The usage of tazerestat must strictly follow the doctor's instructions. The following is a detailed introduction to the use of tazerestat.

Recommended dose

The recommended dose of tazerestat is 800 mg twice daily, taken orally with or without food. Patients should swallow the tablets whole and do not chop, crush or chew the tablets. If you miss a dose or vomit after taking it, there is no need to take a missed dose and you should continue with the next dose as planned.

Dose adjustment of adverse reactions

If patients experience adverse reactions during medication, they should consult a doctor in time and adjust the dose according to the specific situation. The doctor will develop a personalized medication plan based on the patient's tolerance and changes in condition.

Tazerestat treatment should be continued until disease progression or unacceptable toxicity occurs. Patients should return for regular follow-up visits to monitor treatment effects and physical condition.

Tazerestat’s use in special populations

Tazerestat should be used with special caution in special populations, including pregnant women, lactating women, the elderly and children.

Pregnant and lactating women

Pregnant women using tazerestat may cause harm to the fetus, so they need to be used with caution under the guidance of a doctor. Nursing women should avoid breastfeeding during treatment and for one week after stopping the drug to reduce potential risks to the infant.

Elderly

When elderly patients use tazerestat, the dose needs to be adjusted according to individual conditions and doctor’s recommendations. Since the elderly may have poor metabolism and tolerance of drugs, close monitoring is required during medication.

Children

The safety and effectiveness of tazetostat has been established in pediatric patients 16 years of age and older, but its safety and effectiveness have not been established in children under 16 years of age. Medication for pediatric patients must be carried out under the guidance of a doctor.

When using tazerestat, special groups should fully understand the potential risks of the drug and strictly follow the doctor's instructions.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。